Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-26-021610

Chief Financial Officer gave up 72 shares (to pay taxes)

  • Chief Financial Officer acquired 283 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Foster Jonathan P. · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-20 Exercise or conversion : show line 1 in the form +109 12,238 D
2026-06-20 Shares withheld for taxes : show line 2 in the form −31 $2.88 $89 12,207 D
2026-06-22 Exercise or conversion : show line 3 in the form +174 12,381 D
2026-06-22 Shares withheld for taxes : show line 4 in the form −41 $3.12 $128 12,340 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-06-20 Exercise or conversion : show line 5 in the form Restricted Stock Units −109 147,892 D
2026-06-22 Exercise or conversion : show line 6 in the form Restricted Stock Units −174 147,718 D
Loading xslF345X06/rdgdoc.xml…